Clinical Trial Update: Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of an interleukin-2 gargle for treating oral mucosa lesions in pemphigus vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus Vulgaris

Drugs mentioned

• Interleukin-2 gargle (interleukin-2 gargle)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Pemphigus Vulgaris | Phase 2 | Status: UNKNOWN